Atria Investments LLC Exelixis, Inc. Transaction History
Atria Investments LLC
- $7.93 Billion
- Q2 2025
A detailed history of Atria Investments LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Atria Investments LLC holds 8,144 shares of EXEL stock, worth $336,754. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,144
Previous 6,230
30.72%
Holding current value
$336,754
Previous $230,000
55.65%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EXEL
# of Institutions
688Shares Held
260MCall Options Held
1.41MPut Options Held
1.55M-
Black Rock Inc. New York, NY33.5MShares$1.39 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA27.5MShares$1.14 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA16MShares$663 Million3.18% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.8MShares$654 Million0.99% of portfolio
-
State Street Corp Boston, MA11.4MShares$471 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $13.3B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...